Enzon Pharmaceuticals Inc (NASDAQ:ENZN)

1.05
Delayed Data
As of Feb 27
 -0.04 / -3.67%
Today’s Change
0.73
Today|||52-Week Range
1.66
+6.16%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
Revenue and IncomeNet Revenues50.2M43.1M42.6M34.5M
 
 
 
 
 
Cost of Goods Sold51.2M35.8M--0.00
 
 
 
Depreciation And Amortization5.8M5.3M4.3M232.0K
 
 
 
 
 
 
Operating ExpensesGross Income-6.8M2.0M--34.3M
 
 
 
 
General Expenses27.4M17.4M31.2M11.3M
 
 
 
 
 
Research And Development----21.0M2.7M
 
 
 
Total Operating Expenses84.4M58.5M35.5M11.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-34.2M-15.4M7.1M22.9M
 
 
 
 
 
Extraordinary Credit0.005.0M177.0K--
 
 
 
Extraordinary Charge-14.9M-6.0M-11.5M-4.8M
 
 
 
 
 
Interest Expense On Debt6.3M5.9M5.3M2.1M
 
 
 
 
 
Other Expenses48.9M91.0K912.0K1.9M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-3.1M-20.6M-6.9M18.1M
 
 
 
 
 
Income Taxes-337.0K-205.0K-4.1M-28.0K
 
 
 
 
 
Discontinued Operations3.6M0.000.000.00
 
 
Extraordinary Items176.4M0.000.000.00
 
 
Net Income820.0K-20.8M-2.8M18.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS58.5M51.9M46.7M43.8M
 
 
 
 
 
Shares To Calculate EPS Diluted58.5M51.9M46.7M51.0M
 
 
 
 
 
 
Earnings Per ShareEPS$3.03-$0.40-$0.06$0.38
 
 
 
 
 
EPS Diluted$0.01-$0.40-$0.06$0.36
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account